J&J | JNJ - Le Chiffre D'Affaires De Vente





Ventes Changement Date
AbbVie USD 16.99B 1.99B 2026-06
Abbott USD 12.59B 1.43B 2026-06
Amgen USD 10.1B 1.48B 2026-06
AstraZeneca USD 15.38B 90M 2026-06
Baxter International USD 2.96B 260M 2026-06
Bayer EUR 10.87B 2.54B 2026-06
Becton, Dickinson and Co. USD 5B 300M 2026-06
Biogen USD 2.74B 490M 2026-06
Boston Scientific USD 5.44B 240M 2026-06
Bristol-Myers Squibb USD 12.97B 1.48B 2026-06
CONMED USD 343.5M 26.5M 2026-06
Cooper Companies USD 1.08B 57.4M 2026-03
Dexcom USD 1.31B 120M 2026-06
Edwards Lifesciences USD 1.74B 90M 2026-06
Eli Lilly USD 22.97B 3.17B 2026-06
Gilead Sciences USD 7.8B 800M 2026-06
GlaxoSmithKline GBP 8.41B 781M 2026-06
Globus Medical USD 789.61M 29.76M 2026-06
Insulet USD 801.7M 40M 2026-06
Integra LifeSciences USD 418.8M 26.9M 2026-06
Intuitive Surgical USD 2.89B 120M 2026-06
J&J USD 25.31B 1.21B 2026-06
Medtronic USD 9.8B 800M 2026-03
Merck USD 16.6B 310M 2026-06
Merit Medical Systems USD 418.8M 36.9M 2026-06
Novartis USD 14.41B 1.3B 2026-06
Pfizer USD 15.03B 530M 2026-06
Regeneron Pharmaceuticals USD 4.29B 690M 2026-06
Roche Holding CHF 30.36B 14.71B 2026-06
Sanofi EUR 11.95B 710M 2026-06
Stryker USD 6.6B 600M 2026-06
Tandem Diabetes Care USD 254.6M 7.38M 2026-06
Teva Pharmaceutical Industries USD 12.67B 900M 2026-06
Vertex Pharmaceuticals USD 3.33B 340M 2026-06
Zimmer Biomet Holdings USD 2.18B 90M 2026-06
Zoetis USD 2.5B 200M 2026-06